Title:
ナノ粒子製剤
Document Type and Number:
Japanese Patent JP6483017
Kind Code:
B2
Abstract:
The present invention concerns nanoparticle formulations suitable for the delivery of one or more therapeutic agents, the formulations comprising: a cationic cholesterol derivative; a neutral phospholipid; cholesterol or a neutral cholesterol derivative; and a saturated fatty acid, PEGylated neutral derivative of phosphatidylethanolamine or phosphatidylcholine.
Inventors:
Bell, Jimmy
Thomas, Elizabeth Louise
Brody, Ray
Arisoil, Meriz Safri
Mirror, Andrew
Frost, gully
Thomas, Elizabeth Louise
Brody, Ray
Arisoil, Meriz Safri
Mirror, Andrew
Frost, gully
Application Number:
JP2015529120A
Publication Date:
March 13, 2019
Filing Date:
August 28, 2013
Export Citation:
Assignee:
Medical Research Council
International Classes:
A61K9/127; A61K31/19; A61K31/519; A61K45/00; A61K47/24; A61K47/28; A61K47/54; A61K47/60; A61P3/04; A61P3/10; A61P9/00; A61P9/10; A61P25/08; A61P35/00
Domestic Patent References:
| JP2012509258A | ||||
| JP2000510151A | ||||
| JP2002532407A | ||||
| JP2009509531A |
Other References:
新化粧品ハンドブック,2006年,711-721
フレグランスジャーナル ,1996年,24(9),70-78
フレグランスジャーナル ,1996年,24(9),70-78
Attorney, Agent or Firm:
Takashima Ichi
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma